Procedural safety and mid-term outcomes after valve-in-valve transcatheter aortic valve implantation: a prospective single-center study

View at publisher Summarise with VIRAT
Authors: G Papadopoulos, Ilias Ninios, Sotirios Evangelou, A Ioannides, Athinodoros Nikitopoulos, Grigorios Giamouzis, Vlasis N. Ninios
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Background/Introduction Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is the preferred therapy for degenerated surgical bioprostheses, yet residual gradients, patient–prosthesis mismatch (PPM), and coronary obstruction remain major concerns. Purpose This study aims to assess procedural safety and mid-to-long term outcomes in a prospective ViV TAVI cohort. Methods This is a prospective single-center cohort of consecutive patients with symptomatic structural valve degeneration (NYHA III–IV) undergoing transfemoral ViV TAVI between July 2022 and June 2025. Outcomes followed VARC-3 definitions with echocardiography at discharge, 30 days, and 1 year. Exploratory modeling examined predictors of elevated 1-year gradients and PPM. Results Sixty-eight patients (51% female; mean age 77 ± 7 years; EuroSCORE II 7.3 ± 1.8%) were treated. Failure mechanism was stenosis in 50%, regurgitation 22%, mixed 28%; mean true ID 22 ± 3 mm, with 35% ≤21 mm. Valve fracture was performed in 24% (n=16). Commissural alignment was successful in 98.5%. Coronary protection was used in 11.8% (n=8); chimney stenting in 5.9% (n=4), all preserving flow. Technical success was 100%. Thirty-day outcomes: mortality 0%, stroke 0%, MI 0%, new pacemaker 2.9%, major vascular complication 1.5%. Mean transvalvular gradient decreased from 38.0 ± 9.5 mmHg to 6.6 ± 2.0 mmHg post-procedure (p

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Aortic Disease and Treatment Approaches Infective Endocarditis Diagnosis and Management

Publication details

Journal / source
European Heart Journal Supplements
Volume
28
Issue
Supplement_3
Publication date
1 March 2026
Language
EN